ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib.
Saved in:
| Title: | ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib. |
|---|---|
| Authors: | Thunnissen, E.1 (AUTHOR) e.thunnissen@amsterdamumc.nl, Lissenberg-Witte, B.I.2 (AUTHOR), van den Heuvel, M.M.3 (AUTHOR), Monkhorst, K.4 (AUTHOR), Skov, B.G.5 (AUTHOR), Sørensen, J.B.6 (AUTHOR), Mellemgaard, A.7 (AUTHOR), Dingemans, A.M.C.8 (AUTHOR), Speel, E.J.M.9 (AUTHOR), de Langen, A.J.10 (AUTHOR), Hashemi, S.M.S.10 (AUTHOR), Bahce, I.10 (AUTHOR), van der Drift, M.A.11 (AUTHOR), Looijen-Salamon, M.G.12 (AUTHOR), Gosney, J.13 (AUTHOR), Postmus, P.E.14 (AUTHOR), Samii, S.M.S.15 (AUTHOR), Duplaquet, F16 (AUTHOR), Weynand, B.17 (AUTHOR), Durando, X.18 (AUTHOR) |
| Source: | Lung Cancer (01695002). Dec2019, Vol. 138, p13-18. 6p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 140090791 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Thunnissen%2C+E%2E%22">Thunnissen, E.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> e.thunnissen@amsterdamumc.nl</i><br /><searchLink fieldCode="AR" term="%22Lissenberg-Witte%2C+B%2EI%2E%22">Lissenberg-Witte, B.I.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22van+den+Heuvel%2C+M%2EM%2E%22">van den Heuvel, M.M.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Monkhorst%2C+K%2E%22">Monkhorst, K.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Skov%2C+B%2EG%2E%22">Skov, B.G.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sørensen%2C+J%2EB%2E%22">Sørensen, J.B.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mellemgaard%2C+A%2E%22">Mellemgaard, A.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dingemans%2C+A%2EM%2EC%2E%22">Dingemans, A.M.C.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Speel%2C+E%2EJ%2EM%2E%22">Speel, E.J.M.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22de+Langen%2C+A%2EJ%2E%22">de Langen, A.J.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hashemi%2C+S%2EM%2ES%2E%22">Hashemi, S.M.S.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bahce%2C+I%2E%22">Bahce, I.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22van+der+Drift%2C+M%2EA%2E%22">van der Drift, M.A.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Looijen-Salamon%2C+M%2EG%2E%22">Looijen-Salamon, M.G.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gosney%2C+J%2E%22">Gosney, J.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Postmus%2C+P%2EE%2E%22">Postmus, P.E.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Samii%2C+S%2EM%2ES%2E%22">Samii, S.M.S.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Duplaquet%2C+F%22">Duplaquet, F</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Weynand%2C+B%2E%22">Weynand, B.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Durando%2C+X%2E%22">Durando, X.</searchLink><relatesTo>18</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Lung+Cancer+%2801695002%29%22">Lung Cancer (01695002)</searchLink>. Dec2019, Vol. 138, p13-18. 6p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=140090791 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.lungcan.2019.09.023 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 6 StartPage: 13 Titles: – TitleFull: ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Thunnissen, E. – PersonEntity: Name: NameFull: Lissenberg-Witte, B.I. – PersonEntity: Name: NameFull: van den Heuvel, M.M. – PersonEntity: Name: NameFull: Monkhorst, K. – PersonEntity: Name: NameFull: Skov, B.G. – PersonEntity: Name: NameFull: Sørensen, J.B. – PersonEntity: Name: NameFull: Mellemgaard, A. – PersonEntity: Name: NameFull: Dingemans, A.M.C. – PersonEntity: Name: NameFull: Speel, E.J.M. – PersonEntity: Name: NameFull: de Langen, A.J. – PersonEntity: Name: NameFull: Hashemi, S.M.S. – PersonEntity: Name: NameFull: Bahce, I. – PersonEntity: Name: NameFull: van der Drift, M.A. – PersonEntity: Name: NameFull: Looijen-Salamon, M.G. – PersonEntity: Name: NameFull: Gosney, J. – PersonEntity: Name: NameFull: Postmus, P.E. – PersonEntity: Name: NameFull: Samii, S.M.S. – PersonEntity: Name: NameFull: Duplaquet, F – PersonEntity: Name: NameFull: Weynand, B. – PersonEntity: Name: NameFull: Durando, X. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: Dec2019 Type: published Y: 2019 Identifiers: – Type: issn-print Value: 01695002 Numbering: – Type: volume Value: 138 Titles: – TitleFull: Lung Cancer (01695002) Type: main |
| ResultId | 1 |